United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70518-3512_58c5fe3c-eb79-bd8f-e063-6394a90aa925
- Product NDC
- 70518-3512
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Ondansetron
- Labeler
- REMEDYREPACK INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220907
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0) · 70518-3512-0
- 6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1) · 70518-3512-1
- 10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-2) · 70518-3512-2
- 9 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5) · 70518-3512-5
- 15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7) · 70518-3512-7
- 3 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8) · 70518-3512-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →